Evaluation of a low cost cryopreservation system on the biology of human amniotic fluid-derived mesenchymal stromal cells

Cryobiology. 2012 Jun;64(3):160-6. doi: 10.1016/j.cryobiol.2012.01.003. Epub 2012 Jan 20.

Abstract

Background: Human amniotic-derived mesenchymal stromal cells (hAMSC) are a novel population of multipotent stem cells that have been shown to have great potential for use in regenerative medicine. However, procedures to store and preserve hAMSC for future clinical applications have not been explored extensively.

Methods: In this study, we analyzed the influence of cryopreservation, using a protocol based on freezing rate of 1 °C/min, 10% dimethyl sulfoxide as cryoprotectant and a thawing rate >100 °C/min, on hAMSC morphology, proliferation rates, viability, cell cycle, karyotype, immune phenotype and multilineage differentiation potential.

Results: This study found that this cryopreservation protocol does not affect the biological properties of hAMSC.

Discussion: This shows that this protocol is a viable system for banking hAMSC, with the associated advantages that has a low cost in terms of expense, time and personnel involved and is easy to implement.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amniotic Fluid / cytology*
  • Amniotic Fluid / drug effects
  • Biological Specimen Banks
  • Cell Count
  • Cell Cycle / drug effects
  • Cell Differentiation / drug effects
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cryopreservation / economics
  • Cryopreservation / methods*
  • Cryoprotective Agents / pharmacology*
  • Dimethyl Sulfoxide / pharmacology*
  • Humans
  • Immunophenotyping
  • Karyotyping
  • Mesenchymal Stem Cells / cytology*
  • Mesenchymal Stem Cells / drug effects

Substances

  • Cryoprotective Agents
  • Dimethyl Sulfoxide